Albion KAY VCT PLC
Interim Management Statement
LEI Code 213800DK8H27QY3J5R45
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed...